DCVC

DCVC is on record against 33 companies, each listed on its own site.

One of these companies has a funding record on file.

• Auron Therapeutics, Inc.Auron Therapeutics in the portfolio · Form D on file

DCVC has 7 venture fund vehicles on file with the SEC, run from Palo Alto, California, with first sales running from 2022 to 2026. 10 Form D notices, originals and amendments, have been filed for them, the first on December 8, 2022 and the latest on October 8, 2026. Together they have taken in $1,517,079,500 from 210 investor positions, most recently on August 18, 2026. 5 vehicles are still showing room to take more.

The filings for these vehicles name 4 people and entities, with the role each filing gives.

• Zachary BogueManaging Member of the Managing Member; Managing Member of the General Partner; Managing Member of the Managing Member of the General Partner
• Matthew OckoManaging Member of the Managing Member; Managing Member of the General Partner; Managing Member of the Managing Member of the General Partner
• Kiersten SteadManaging Member of the Managing Member of the General Partner
• John HamerManaging Member of the Managing Member of the General Partner

The firm invests at seed through Series A, focusing on sectors applying modern computation like AI and simulation to agriculture, mining, manufacturing, health, and defense. Geographic focus is global, with an emphasis on partners’ hard-science and national-security expertise.

• 11.2 CapitalAlso backs Auransa
• Bling CapitalAlso backs Airtable
• CantosAlso backs Atom Computing
• Fifty YearsAlso backs Advano
• GTMFundAlso invests at the seed and Series A stages